W
ASHINGTON — Representatives from the drug industry’s top lobbying group will head to the White House Tuesday morning for a rendezvous with President Trump.
Steve Ubl, president and CEO of the Pharmaceutical Research and Manufacturers of America, and several of PhRMA’s board members will meet with Trump and Vice President Mike Pence at 9 a.m. in the Oval Office.
Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!
SUBSCRIBE TODAYWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
Just give him some drugs for his mental condition…